Serious Infections after Tocilizumab Administration in Patients with Rheumatoid Arthritis: A Retrospective Study Using an Adverse Drug Reaction Database -Analysis of Clinical Symptoms and Laboratory Test Data in Serious Infections
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000024071
- Lead Sponsor
- CHUGAI PHARMACEUTICAL CO.,LTD. DRUG SAFTY DATA MANAGEMENT DEPT.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 7653
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify the initial symptoms before developing serious infection (SI) in the TCZ treated patients by using the clinical narratives from Post-marketing adverse events reporting database.
- Secondary Outcome Measures
Name Time Method